KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Debt to Equity (2019 - 2025)

Historic Debt to Equity for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $0.81.

  • GoodRx Holdings' Debt to Equity rose 1540.88% to $0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.81, marking a year-over-year increase of 1540.88%. This contributed to the annual value of $0.68 for FY2024, which is 2124.47% down from last year.
  • Per GoodRx Holdings' latest filing, its Debt to Equity stood at $0.81 for Q3 2025, which was up 1540.88% from $0.76 recorded in Q2 2025.
  • GoodRx Holdings' Debt to Equity's 5-year high stood at $1.04 during Q1 2024, with a 5-year trough of $0.68 in Q4 2024.
  • For the 5-year period, GoodRx Holdings' Debt to Equity averaged around $0.81, with its median value being $0.81 (2021).
  • Its Debt to Equity has fluctuated over the past 5 years, first surged by 3292.14% in 2024, then crashed by 2758.59% in 2025.
  • GoodRx Holdings' Debt to Equity (Quarter) stood at $0.8 in 2021, then grew by 1.44% to $0.81 in 2022, then increased by 6.56% to $0.86 in 2023, then fell by 21.24% to $0.68 in 2024, then rose by 20.0% to $0.81 in 2025.
  • Its Debt to Equity stands at $0.81 for Q3 2025, versus $0.76 for Q2 2025 and $0.75 for Q1 2025.